New Key Statistics Module, Z-Score and F-Score
NAS:SPRO Key Ratios
| Market Cap $ M | 72.38 |
| Enterprise Value $ M | 18.72 |
| P/E(ttm) | 5.21 |
| PE Ratio without NRI | 4.98 |
| Forward PE Ratio | 1.80 |
| Price/Book | 1.37 |
| Price/Sales | 1.49 |
| Price/Free Cash Flow | 8.37 |
| Price/Owner Earnings | -- |
| Payout Ratio % | -- |
| Revenue (TTM) $ M | 54.00 |
| EPS (TTM) $ | 0.24 |
| Beneish M-Score | -1.4 |
| 10-y EBITDA Growth Rate % | -- |
| 5-y EBITDA Growth Rate % | -- |
| y-y EBITDA Growth Rate % | -- |
| EV-to-EBIT | 1.32 |
| EV-to-EBITDA | 1.32 |
| PEG | -- |
| Shares Outstanding M | 57.90 |
| Net Margin (%) | 27.82 |
| Operating Margin % | 25.89 |
| Pre-tax Margin (%) | 28.30 |
| Quick Ratio | 10.50 |
| Current Ratio | 10.50 |
| ROA % (ttm) | 23.66 |
| ROE % (ttm) | 37.14 |
| ROIC % (ttm) | 90.76 |
| Dividend Yield % | -- |
| Altman Z-Score | -0.77 |
SPRO Number of Guru Trades
SPRO Volume of Guru Trades
Gurus Latest Trades with NAS:SPRO
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NAS:SPRO is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Spero Therapeutics Inc Insider Transactions
No Available Data
News about NAS:SPRO
Total 0- 1
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers